Clinical Study

Autosomal Dominant Polycystic Kidney Disease (Adpkd) Testing An Investigational Drug

Posted Date: Aug 22, 2016

  • Investigator: Shashi Kant
  • Co-Investigator: Shashi Kant
  • Specialties:
  • Type of Study: Drug

This study will evaluate the safety and effectiveness of an investigational medication called tolvaptan in patients with late stage 2 to early stage 4 chronic kidney disease caused by autosomal dominant polycystic kidney disease (ADPKD). The kidney fun

Criteria:

You May Be Able To Join The Study If You Are: • Between The Ages Of 18 To 55 Years Old; Patients Aged 56 To 65 May Be Able To Participate In Some Circumstances • Diagnosed With Adpkd

Keywords:

Polycystic, Tolvaptan, Kidney, Autosomal, Null

For More Information:

Angela Gordon
513-281-0091 ext 117
angela.gordon@uc.edu

  • Search Clinical Studies

  • Research in the News

    Targeted Treatment Could Prevent Spread of Pancreatic Cancer, Heart Damage

    Researchers at the UC College of Medicine have shown that a new targetedtreatment could benefit patients with certain pancreatic tumors.